Navigation Links
Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results
Date:8/10/2009

come of $0.4 million for the second quarter of 2008. The decrease was primarily attributable to lower dividend and interest income from lower cash, cash equivalent and investment balances.

Other expense, net, increased $35.9 million primarily as a result of a non-cash charge relating to the mark-to-market valuation adjustment to our warrant liability during the second quarter of 2009.

Our income tax benefit decreased $1.6 million to zero for the second quarter of 2009, as we no longer have the ability to carry back losses to previous years to recover taxes paid and it is uncertain that we will be able to utilize these net operating losses against future income. The 2008 income tax benefit reflects the tax effects of the carry back of our 2008 net operating losses to the 2006 tax year to recover 2006 income taxes paid.

Financial Results of Operations for the Six Months Ended June 30, 2009

Total revenues for the first six months of 2009 were $1.8 million compared with $1.5 million for the same period of 2008, an increase of $0.3 million. The increase was primarily the result of higher sales of oxandrolone, due to increased market share achieved by our authorized generic distributor.

Cost of goods sold for the first six months of 2009 were $0.9 million compared with $0.6 million for the same period of 2008, an increase of $0.3 million. The increase in cost of goods sold resulted primarily from higher gross sales of oxandrolone.

Research and development expenses for the first six months of 2009 were $24.4 million, compared with $26.9 million for the same period of 2008, a decrease of $2.5 million. The decrease was primarily due to lower technology transfer expenses of $2.4 million as we near the completion of the technology transfer related to developing our secondary source supplier of pegloticase API. In addition, manufacturing capacity reservation
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Savient Pharmaceuticals to Present at the Credit Suisse Phoenix Healthcare Conference on November 13th
2. Savients Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase
3. Savient Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 14th
4. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results
5. Savient Pharmaceuticals to Present at The Cowen and Company 29th Annual Healthcare Conference on March 17, 2009
6. Savient Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for KRYSTEXXA(TM)
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
9. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... 2015 , ... B. E. Smith, the only full-service leadership ... national chief executive officer recruitment for Citizens Medical Center in Victoria, ... E. Smith has recently placed more than 1,000 healthcare executives into organizations. ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... compact, battery-operated ML-T balance line. With larger-than-average weighing pans, ML-T balances give operators ... scale’s smallest in-class footprint, this extra real estate makes ML-T balances a perfect ...
(Date:7/1/2015)... ... ... The Thule Atmos X4 offers protection with minimal bulk. At the Thule Test ... standards. Due to its Bi-ComponentArmor and ShockStop corners, it passed Thule’s 2 meter drop ... , The Thule Atmos X4 has also been designed with function in mind. ...
(Date:7/1/2015)... ... July 01, 2015 , ... Foot and Ankle Specialists of ... ) participated in the annual Howard County Family Wellness Day event at Centennial Park ... included wellness screenings, activities for children, free workout demonstrations, and more. Drs. Becker ...
(Date:7/1/2015)... ... July 01, 2015 , ... Seldon Technologies, a leading developer ... water fountain manufacturer, Bebederos Ecologicos / Ottone Meloda to provide clean drinking water ... among the top environmental legislators by the nation’s foremost conservation organizations, will speak ...
Breaking Medicine News(10 mins):Health News:Citizens Medical Center Retains B. E. Smith to Recruit New CEO 2Health News:Citizens Medical Center Retains B. E. Smith to Recruit New CEO 3Health News:METTLER TOLEDO Launches Compact ML-T Balances: Larger Pan Offers Greater Weighing Flexibility in Tight Spaces 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Promotes Healthy Living 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Promotes Healthy Living 3Health News:Clean Drinking Water Now Available to Millions of Mexican Children as a Result of Partnership Between Seldon Technologies and Bebederos Ecologicos / Ottone Meloda 2Health News:Clean Drinking Water Now Available to Millions of Mexican Children as a Result of Partnership Between Seldon Technologies and Bebederos Ecologicos / Ottone Meloda 3
... While most skin cancer patients,would like nothing more ... carry constant reminders of their battle with cancer ... skin cancer surgical scars can cause,serious disfigurement, particularly ... camouflage. Now, thanks to pioneering research, dermatologists can ...
... promising news in the quest to find a therapy ... or Lou Gehrigs disease, scientists at the University of ... that targeting neuronal support cells called astrocytes sharply slows ... the laboratory of Don Cleveland, Ph.D., UCSD Professor of ...
... Medicine have implemented patient safety enhancements to dramatically reduce ... safety climate in obstetrical care. , Edmund F. ... Gynecology & Reproductive Sciences at Yale, will present preliminary ... Fetal Medicine Annual Meeting on February 2 in Dallas, ...
... Africa, Feb. 1 Kristin Davis, star,of US hit ... Oxfam and leading AIDS,activists at a Johannesburg press conference ... the HIV and AIDS epidemic in,South Africa., (Photo: ... http://www.newscom.com/cgi-bin/prnh/20080201/LAF106-b ) ...
... Alma Lasers Ltd. ("Alma,Lasers"), a global developer ... aesthetic devices, announced today that it will,unveil five ... the American Academy,of Dermatology (AAD) in San Antonio, ... be available during this time to discuss Alma,Lasers, ...
... Feb. 1 Divided We Fail volunteers,from across ... Tuesday,s,Presidential Primary to press candidates and elected officials ... long-term financial security,top issues in the national political ... representing big business, small,business, labor and consumers to ...
Cached Medicine News:Health News:New Technology and Improved Techniques Arm Dermatologists With Tools to Minimize Facial Scars From Skin Cancer Surgery 2Health News:New Technology and Improved Techniques Arm Dermatologists With Tools to Minimize Facial Scars From Skin Cancer Surgery 3Health News:New Technology and Improved Techniques Arm Dermatologists With Tools to Minimize Facial Scars From Skin Cancer Surgery 4Health News:Targeting astrocytes slows disease progression in ALS 2Health News:New strategy helps reduce errors in obstetrical care 2Health News:'Sex & the City' Gets Serious About HIV and AIDS in South Africa - Kristin Davis Helps Oxfam Break the Stigma and Close the Treatment Gaps Fuelling AIDS 2Health News:'Sex & the City' Gets Serious About HIV and AIDS in South Africa - Kristin Davis Helps Oxfam Break the Stigma and Close the Treatment Gaps Fuelling AIDS 3Health News:Alma(TM) Lasers to Debut Five New Products at the 66th Annual Meeting of the American Academy of Dermatology 2Health News:Divided We Fail to Ramp Up Efforts in Delaware Leading up to Super Tuesday 2
(Date:6/30/2015)... , June 30, 2015 First Choice ... to the Astanza Duality and is the only clinic ... offering professional tattoo removal treatments. The practice has recently ... Removal brand to showcase their focus in the ... residents better results, faster ink clearance, and superior service. ...
(Date:6/30/2015)... 2015 Oramed Pharmaceuticals Inc. (NASDAQ: ... Company focused on the development of oral drug delivery ... screened in the Company,s Phase IIb trial of its ... be performed under the active Investigational New Drug (IND) ... Administration (FDA). The Phase IIb study for ...
(Date:6/30/2015)... 30, 2015  EnteroMedics Inc. (NASDAQ: ETRM ), ... technology to treat obesity, metabolic diseases, and other gastrointestinal ... offering  of 40,229,886 units. Each unit consists of one ... warrant to purchase one share of common stock, and ... share of common stock, at a purchase price of ...
Breaking Medicine Technology:First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 2First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 3Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 2Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 3EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 3
... Sibutramine -- ABBOTT PARK, Ill., Sept. 15 ... ... ... Results are keyed by longUrl, so we need to grab the first one. for (var r in ...
... RATON, Fla., Sept. 15 Watermark Medical , ... the sleep-disordered breathing market, has expanded the market reach ... strategic alliances with three leading sleep solution providers in ... SleepQuest , a national provider of comprehensive sleep apnea ...
Cached Medicine Technology:Abbott Statement on the FDA Advisory Committee Recommendation on Sibutramine 2Abbott Statement on the FDA Advisory Committee Recommendation on Sibutramine 3Abbott Statement on the FDA Advisory Committee Recommendation on Sibutramine 4Abbott Statement on the FDA Advisory Committee Recommendation on Sibutramine 5Abbott Statement on the FDA Advisory Committee Recommendation on Sibutramine 6Abbott Statement on the FDA Advisory Committee Recommendation on Sibutramine 7Abbott Statement on the FDA Advisory Committee Recommendation on Sibutramine 8Abbott Statement on the FDA Advisory Committee Recommendation on Sibutramine 9Three Leading Sleep Solution Providers Choose Watermark Medical's Web-Enabled Home Sleep Testing Solutions 2Three Leading Sleep Solution Providers Choose Watermark Medical's Web-Enabled Home Sleep Testing Solutions 3Three Leading Sleep Solution Providers Choose Watermark Medical's Web-Enabled Home Sleep Testing Solutions 4
For the qualitative detection of IgG/IgM antibodies to B. burgdorferi...
... surgical-quality loupes available at manufacturer-direct ... innovative optical design, combining superior quality ... with maximum comfort, SheerVision loupes are ... worldwide. Make both a professional and ...
... surgical-quality loupes available at manufacturer-direct ... innovative optical design, combining superior quality ... with maximum comfort, SheerVision loupes are ... worldwide. Make both a professional and ...
... the first manufacturer to offer through-the-lens ... wearer. These next generation loupes feature ... ultra-lightweight design, and are multi-coated lens ... With SheerVision's proprietary SureFit system - ...
Medicine Products: